☆ 4.7 Article

Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Caveolin-1 ameliorates acetaminophen-aggravated inflammatory damage and lipid deposition in non-alcoholic fatty liver disease via the ROS/TXNIP/NLRP3 pathway

Xiangfu Jiang et al.

Summary: The overuse of acetaminophen (APAP) may cause more severe hepatotoxicity in patients with non-alcoholic fatty liver disease (NAFLD). Caveolin-1 (CAV1) can alleviate liver damage by scavenging reactive oxygen species (ROS). The NLRP3-mediated pyroptosis and the ROS/TXNIP/NLRP3 pathway play important roles in the development of NAFLD.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

Vlad Ratziu et al.

Summary: The study investigated the safety, tolerability, and efficacy of vonafexor in patients with suspected fibrotic NASH. Results showed that vonafexor was safe and induced significant reduction in liver fat, improvement in liver enzymes, weight loss, and a possible renal benefit.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Chemistry, Medicinal

Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR)

Na Zhang et al.

Summary: Sixty-one palmatine derivatives, including twenty-eight new compounds, were synthesized and evaluated for their anti-fibrogenic activities. One compound showed the highest potency and reduced the expressions of fibrogenic biomarkers in a dose-dependent manner. It also significantly attenuated liver fibrosis in a NASH mice model by activating FXR. These findings suggest that palmatine derivatives have potential as non-steroidal FXR agonists for NASH treatment.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Elafibranor modulates ileal macrophage polarization to restore intestinal integrity in NASH: Potential crosstalk between ileal IL-10/STAT3 and hepatic TLR4/NF-ΚB axes

Andrew N. Hakeem et al.

Summary: Experimental and clinical evidence suggest that disrupted gut barrier integrity plays a role in the progression of non-alcoholic steatohepatitis (NASH) by activating innate immune responses, particularly macrophages. Peroxisome proliferator-activated receptors (PPARs), a subset of nuclear receptors, regulate metabolic and inflammatory processes involved in NASH. This study investigated the impact of dual PPAR alpha/delta activation with elafibranor (ELA) on macrophage polarization (MP) in the ileum and its effects on the liver in a NASH setting.

BIOMEDICINE & PHARMACOTHERAPY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Heme induced progesterone-resistant profiling and promotion of endometriosis in vitro and in vivo

Xiao-Qian Ma et al.

Summary: Endometriosis is an estrogen-dependent, progesterone-resistant gynecological disease. In this study, the dysregulated expression of heme-trafficking proteins and heme-degrading enzymes was investigated, revealing that heme mediates progesterone resistance and induces endometriosis via the mitochondrial oxidative phosphorylation pathway.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice

Satoshi Iwai et al.

Summary: A recent study has found that the GLP-1RA medication semaglutide has therapeutic effects on skeletal muscle atrophy in type 2 diabetes patients. The experiment showed that semaglutide effectively inhibits muscle atrophy, improves grip strength, and prevents muscle protein degradation and promotes myogenesis. Mechanistically, semaglutide protects against hepatic injury, reduces inflammation and oxidative stress, activates metabolic processes, and directly stimulates GLP-1R in myocytes.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Apolipoprotein E epsilon 4 triggers neurotoxicity via cholesterol accumulation, acetylcholine dyshomeostasis, and PKCe mislocalization in cholinergic neuronal cells

Rebecca Piccarducci et al.

Summary: The ApoE epsilon 4 polymorphic variant is a major risk factor for Alzheimer's Disease (AD) due to its effects on cholesterol metabolism and cholinergic pathway impairment. In this study, in vitro cholinergic neuron models were used to investigate the interplay between ApoE epsilon 4-related cholesterol metabolism dysregulation and cholinergic system degeneration. The results showed that ApoE epsilon 4 expression led to intracellular cholesterol accumulation and reduced acetylcholine synthesis, resulting in cholinergic pathway impairment and neuronal death.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)

添加到收藏夹

Article Immunology

Released dsDNA-triggered inflammasomes serve as intestinal radioprotective targets

Long Chen et al.

Summary: This study investigated the immunogen of intestinal mucositis during radiotherapy and found that dsDNA released from intestinal epithelial cells may serve as a potential immunogen, triggering inflammasome activation and causing mucositis. Furthermore, the use of the FDA-approved drug disulfiram (DSF) was found to mitigate intestinal radiotoxicity by suppressing inflammasome activation.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA

Longying Jiang et al.

Summary: This study aimed to investigate the mechanism of FXR binding to DNA elements and the heterodimer interactions in the FXR-DBD/RXR-DBD complex through structural, biochemical and bioinformatics analyses. Further biochemical assays showed that RAR, THR, and NR4A2 do not form heterodimers with RXR when bound to the IR1 sites, indicating that IR1 may be a unique binding site for the FXR/RXR heterodimer. These studies could provide a better understanding of dimerization specificity of nuclear receptors.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases

Dong-Hyun Kim et al.

Summary: Targeting the expression and activation of a critical bile acid receptor could be a novel therapeutic approach for kidney diseases.

EXPERIMENTAL AND MOLECULAR MEDICINE (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1

Shu Zeng et al.

Summary: In this study, we found that inhibiting the palmitoylation of FAT/CD36 promotes its localization to the mitochondria of hepatocytes, thereby alleviating NAFLD. Mitochondrial FAT/CD36 acts as a molecular bridge between LCFAs and ACSL1, increasing the production of long-chain acyl-CoA and promoting FAO, thus preventing lipid accumulation and excessive ROS production in hepatocytes.

ANTIOXIDANTS & REDOX SIGNALING (2022)

添加到收藏夹

Review Immunology

Regulation of the NLRP3 Inflammasome by Posttranslational Modifications

Safoura Zangiabadi et al.

Summary: Inflammasomes play a crucial role in human health and disease by controlling the secretion of IL-1β and IL-18, two potent proinflammatory cytokines. Among the inflammasomes, NLRP3 inflammasome is the most well-studied and can be activated by various inducers. Aberrant activation of NLRP3 inflammasomes is implicated in numerous human diseases. This review focuses on the posttranslational modifications that regulate the components of NLRP3 inflammasome.

JOURNAL OF IMMUNOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates

Veronika A. Prikhodko et al.

Summary: This paper provides an update on the rapidly changing therapeutic landscape of non-alcoholic fatty liver disease (NAFLD). It highlights the major novel approaches to the treatment of this disease and reviews the current status of drug discovery and development pipeline, focusing on recent evidence from clinical trials.

BIOMEDICINES (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

The lactate receptor GPR81 mediates hepatic lipid metabolism and the therapeutic effect of metformin on experimental NAFLDs

Guanglu Wu et al.

Summary: GPR81 plays a critical role in hepatic lipid metabolism by modulating the transcription of PGC-1 alpha and controlling the oxidation of fatty acids. Activation of hepatic GPR81 is important for improving NAFLD.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor

Wenjing Xu et al.

Summary: This study found that CSE protein expression is significantly downregulated in the liver of NAFLD patients, and the CSE/H2S pathway is also downregulated. Feeding an HFD to CSE knockout mice resulted in increased hepatic lipid deposition and insulin resistance, which could be attenuated by H2S donor treatment. Furthermore, CSE/H2S was found to promote sulfhydration modification of FXR, enhancing its activity in regulating target gene expression.

HEPATOLOGY (2022)

添加到收藏夹

Article Cell Biology

Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism

Weinan Zhou et al.

Summary: This review examines the classical and non-canonical tissue-specific roles of FXR in regulating lipids and glucose homeostasis, highlighting the significance of FXR signaling in modulating metabolic processes. It also emphasizes that tissue-specific modulation of FXR may be the key to overcoming some of the adverse clinical effects.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2022)

添加到收藏夹

Article Cell Biology

Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4

Wenyi Deng et al.

Summary: FXR plays an important role in nonalcoholic fatty liver disease, regulating glucose and lipid metabolism balance through the modulation of PDK4.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

添加到收藏夹

Editorial Material Medicine, Research & Experimental

Early biochemical observations point to nutritional strategies to manage non-alcoholic fatty liver disease Comment

Philip C. Calder

Summary: Non-alcoholic fatty liver disease (NAFLD), the most prevalent liver disease globally, is influenced by inflammation and oxidative stress. Two papers published in 2004 investigated fatty acids and oxidative stress markers in the livers of NAFLD patients and concluded that low levels of n 3 PUFAs are associated with NAFLD. Moreover, several studies have explored the potential role of supplemental n 3 PUFAs or antioxidants in the treatment of NAFLD.

CLINICAL SCIENCE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage

Chiara Rossi et al.

Summary: The role of inflammasomes in non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and viral-related liver disease has been investigated. The study found that P2X7R-NLRP3 and AIM2 inflammasomes play a major role in liver inflammation accompanying chronic HCV infection and metabolic damage. It also discovered the hepatic expression of IL-2 in NASH, which was previously considered a characteristic of HCV-related liver damage.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway

Rongrong Li et al.

Summary: This study found that VEGFB can participate in lipid metabolism and insulin resistance in NAFLD through the AMPK signaling pathway, further confirming the importance of VEGFB in the pathogenesis of fatty liver disease.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Nutrition & Dietetics

Ferulic Acid Prevents Nonalcoholic Fatty Liver Disease by Promoting Fatty Acid Oxidation and Energy Expenditure in C57BL/6 Mice Fed a High-Fat Diet

Zhixin Luo et al.

Summary: Ferulic acid (FA) has a protective effect on high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) by activating PPARα to decrease triacylglycerol accumulation and increase energy expenditure.

NUTRIENTS (2022)

添加到收藏夹

Article Microbiology

Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity

Julia Muenzker et al.

Summary: This study demonstrates the significant role of the gut microbiome in the energy and metabolic improvements achieved through gastric bypass surgery. By eliminating and transplanting the gut microbiota, the study identifies a signaling cascade involving altered bile acid receptor signaling that readjusts energy imbalance and metabolic diseases in obese hosts.

MICROBIOME (2022)

添加到收藏夹

Article Medicine, Research & Experimental

SEMA7AR148W mutation promotes lipid accumulation and NAFLD progression via increased localization on the hepatocyte surface

Nan Zhao et al.

Summary: The SEMA7AR(148W) mutation is identified as a potentially strong genetic determinant of NAFLD, promoting intrahepatic lipid accumulation and NAFLD by enhancing PKC-alpha-stimulated fatty acid and triglyceride synthesis and fatty acid uptake.

JCI INSIGHT (2022)

添加到收藏夹

Article Environmental Sciences

Cadmium exposure induces pyroptosis in testicular tissue by increasing oxidative stress and activating the AIM2 inflammasome pathway

Jinzhao Zhou et al.

Summary: High doses of cadmium exposure lead to irreversible damage to the testicular tissue, mainly through the activation of pyroptosis pathway. The exposure of Cd significantly decreases testosterone levels, sperm concentration and sperm motility, while increasing LDH and IL-1 beta levels. The transcriptome analysis shows that Cd exposure induces inflammatory and chemokine signaling pathways in the testicular tissue.

SCIENCE OF THE TOTAL ENVIRONMENT (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

The GR-gp78 Pathway is involved in Hepatic Lipid Accumulation Induced by Overexpression of 11β-HSD1

Mengliang Hu et al.

Summary: Glucocorticoids play an essential role in lipid metabolism, and the enzyme 11 beta-HSD1 is crucial for regulating glucocorticoid signaling. This study used cell culture and mouse models to show that overexpression of 11 beta-HSD1 activates glucocorticoid receptors and promotes lipid synthesis through a specific pathway, leading to lipid accumulation. These findings suggest that targeting this pathway could be a potential diagnostic and therapeutic approach for non-alcoholic fatty liver disease.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress

Kang Wei et al.

Summary: The study demonstrates the potential of corn peptides (CPs) in the prevention and auxiliary treatment of non-alcoholic fatty liver disease (NAFLD). CPs were found to effectively reduce lipid accumulation, alleviate insulin resistance, and inhibit oxidative stress.

FOOD & FUNCTION (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

N6-Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes

Bing Zhou et al.

Summary: In this study, it was found that m(6)A enrichment and mRNA expression of lipogenic genes were increased in leptin-receptor-deficient mice. The m(6)A reader, Ythdc2, was down-regulated in obese mice and NAFLD patients, and its suppression in lean mice led to TG accumulation while overexpression in obese mice improved liver steatosis and insulin resistance. This suggests that Ythdc2 plays a crucial role in regulating hepatic lipogenesis and TG homeostasis, presenting a potential target for treating obesity-related NAFLD.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice

Qian Lin et al.

Summary: The study demonstrated that FGF1(oHBS) is effective in preventing and reversing liver steatosis and steatohepatitis by activating AMPK through hepatocyte FGFR4.

HEPATOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatic Kruppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance

Nannan Sun et al.

Summary: The transcription factor KLF16 plays a crucial role in hepatic lipid metabolism by regulating fatty acid oxidation and improving mitochondrial stress and oxidative stress, thus reducing hepatic steatosis and insulin resistance.

GUT (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease

Marc-Olivier Deguise et al.

Summary: The Smn(2B/-) mouse model rapidly develops microvesicular steatohepatitis, providing an opportunity to study the pathogenesis of NAFLD. While not a typical NAFLD/NASH model, it offers a reliable, low-cost, and early-onset model for both adult and pediatric populations.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway

Da Eun Kim et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Emerging Relevance of AIM2 in Liver Disease

Beatriz Lozano-Ruiz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Endocrinology & Metabolism

Genetic and epigenetic factors determining NAFLD risk

Wenke Jonas et al.

MOLECULAR METABOLISM (2020)

添加到收藏夹

Article Medicine, General & Internal

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice

Oren Rom et al.

EBIOMEDICINE (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress

Ge Chenxu et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Molecular pathways of nonalcoholic fatty liver disease development and progression

Fernando Bessone et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor

Junqiao Wang et al.

FOOD & FUNCTION (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro

Xiaoguang Gao et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches

Antonella Borrelli et al.

REDOX BIOLOGY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity

Diego A. Miranda et al.

JCI INSIGHT (2018)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Current and emerging pharmacological therapy for nonalcoholic fatty liver disease

Ahad Eshraghian

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Baicalin protects AML-12 cells from lipotoxicity via the suppression of ER stress and TXNIP/NLRP3 inflammasome activation

Junli Zhang et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development

Pierluigi Ramadori et al.

FREE RADICAL BIOLOGY AND MEDICINE (2016)

添加到收藏夹

Review Gastroenterology & Hepatology

Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin

Jasmine F. Ge et al.

SEMINARS IN LIVER DISEASE (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Fatty liver diseases, bile acids, and FXR

Yan Zhu et al.

ACTA PHARMACEUTICA SINICA B (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Activation of hepatic CREBH and Insig signaling in the anti-hypertriglyceridemic mechanism of R-α-lipoic acid

Xuedong Tong et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

FXR silencing in human colon cancer by DNA methylation and KRAS signaling

Ann M. Bailey et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology

Wen Liang et al.

PLOS ONE (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Mechanisms of STAT3 activation in the liver of FXR knockout mice

Guodong Li et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)

添加到收藏夹

Article Immunology

Critical Role of ASC Inflammasomes and Bacterial Type IV Secretion System in Caspase-1 Activation and Host Innate Resistance to Brucella abortus Infection

Marco Tulio R. Gomes et al.

JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

Jung Sub Lim et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)

添加到收藏夹

Article Multidisciplinary Sciences

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

Teresa Fernandes-Alnemri et al.

NATURE (2009)

添加到收藏夹

Article Gastroenterology & Hepatology

Fenofibrate, a peroxisome proliferator-activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver

Yuichi Harano et al.

LIVER INTERNATIONAL (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.